June 2026 NurtureBio and Lallemand Health Solutions entered a strategic collaboration to commercialize an HMO-based synbiotic supplement for infants and toddlers, combining clinically studied probiotic strains with human milk oligosaccharides to support early-life gut health.
June 2026 SynbioTech launched SYNMUE™, a clinically validated microbiome-based synbiotic solution targeting healthy aging and immune support, expanding its portfolio of functional nutrition products.
May 2026 NurtureBio officially launched its first HMO-based synbiotic supplement for infants and toddlers, expanding the market with a science-backed product targeting digestive and immune health.
December 2025 SynbioTech announced that its proprietary "Symbiotic Fermentation" technology received multiple international innovation awards, strengthening its research and development capabilities for next-generation synbiotic ingredients.
May 2025 Clasado Biosciences expanded its strategic partnership with Probi to develop and commercialize clinically validated synbiotic formulations by combining Bimuno GOS prebiotics with Probi's proprietary probiotic strains.